These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1896711
21. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? Boffa MB, Koschinsky ML. J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358 [Abstract] [Full Text] [Related]
22. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi? Smith EB, Crosbie L. Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924 [Abstract] [Full Text] [Related]
23. [Lipoprotein(a). Its importance as an additional atherosclerosis marker]. Campos E. Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184 [Abstract] [Full Text] [Related]
24. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)). Smith EB, Cochran S. Atherosclerosis; 1990 Oct; 84(2-3):173-81. PubMed ID: 2149268 [Abstract] [Full Text] [Related]
25. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family. Scanu AM. Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066 [Abstract] [Full Text] [Related]
26. [Atherogenic modifications of low density lipoproteins during fibrin formation and fibrinolysis]. Chulkova TM. Vopr Med Khim; 1989 Jul; 35(2):72-5. PubMed ID: 2741416 [Abstract] [Full Text] [Related]
27. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)]. Krempler F. Acta Med Austriaca; 1980 Jul; 7(4-5):101-3. PubMed ID: 6454320 [Abstract] [Full Text] [Related]
28. Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis. Ehnholm C, Jauhiainen M, Metso J. Eur Heart J; 1990 Aug; 11 Suppl E():190-5. PubMed ID: 2146125 [Abstract] [Full Text] [Related]
29. [LP (a) lipoprotein: a new independent risk factor for atherogenesis]. Davidoff P. Rev Med Chil; 1991 Jan; 119(1):64-8. PubMed ID: 1840458 [Abstract] [Full Text] [Related]
30. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis]. Kullich W, Machreich K. Wien Med Wochenschr; 1994 Jan; 144(17):407-11. PubMed ID: 7839688 [Abstract] [Full Text] [Related]
37. Inhibition of fibrinolysis by lipoprotein(a). Anglés-Cano E, de la Peña Díaz A, Loyau S. Ann N Y Acad Sci; 2001 Jan; 936():261-75. PubMed ID: 11460483 [Abstract] [Full Text] [Related]
38. Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans? Kostner GM, Bihari-Varga M. Eur Heart J; 1990 Aug; 11 Suppl E():184-9. PubMed ID: 2146124 [Abstract] [Full Text] [Related]
39. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Horejsí B, Ceska R. Physiol Res; 2000 Aug; 49 Suppl 1():S63-9. PubMed ID: 10984073 [Abstract] [Full Text] [Related]
40. Lipoprotein(a) and atherosclerosis. Scanu AM, Lawn RM, Berg K. Ann Intern Med; 1991 Aug 01; 115(3):209-18. PubMed ID: 1829339 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]